(0.23%) 5 143.25 points
(0.23%) 38 530 points
(0.32%) 17 903 points
(-0.95%) $83.05
(1.82%) $1.958
(-0.20%) $2 342.60
(0.00%) $27.54
(0.43%) $926.10
(-0.17%) $0.933
(-0.09%) $11.01
(-0.25%) $0.798
(0.74%) $92.56
-0.30% INR 1 588.00
Live Chart Being Loaded With Signals
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally...
Stats | |
---|---|
Šios dienos apimtis | 2 158.00 |
Vidutinė apimtis | 20 688.00 |
Rinkos kapitalizacija | 22.44B |
EPS | INR0 ( 2024-02-01 ) |
Kita pelno data | ( INR0 ) 2024-05-20 |
Last Dividend | INR10.00 ( 2023-07-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 34.56 |
ATR14 | INR3.19 (0.20%) |
Tūris Koreliacija
TTK Healthcare Limited Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
TTK Healthcare Limited Koreliacija - Valiuta/Žaliavos
TTK Healthcare Limited Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR7.25B |
Bruto pelnas: | INR3.77B (52.04 %) |
EPS: | INR452.73 |
FY | 2022 |
Pajamos: | INR7.25B |
Bruto pelnas: | INR3.77B (52.04 %) |
EPS: | INR452.73 |
FY | 2022 |
Pajamos: | INR5.96B |
Bruto pelnas: | INR3.09B (51.85 %) |
EPS: | INR13.10 |
FY | 2021 |
Pajamos: | INR6.37B |
Bruto pelnas: | INR3.83B (60.10 %) |
EPS: | INR32.87 |
Financial Reports:
No articles found.
TTK Healthcare Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR3.50 | 2010-07-16 |
Last Dividend | INR10.00 | 2023-07-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | INR73.00 | -- |
Avg. Dividend % Per Year | 0.72% | -- |
Score | 1.73 | -- |
Div. Sustainability Score | 1.790 | |
Div.Growth Potential Score | 3.58 | |
Div. Directional Score | 2.69 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR5.00 | 0.48% |
2019 | INR5.00 | 0.63% |
2020 | INR3.00 | 0.61% |
2021 | INR6.00 | 1.03% |
2022 | INR10.00 | 1.40% |
2023 | INR10.00 | 0.98% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TRU.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.01% | |
PIXTRANS.NS | Dividend Junior | 2023-07-11 | Semi-Annually | 3 | 0.43% | |
JKLAKSHMI.NS | Dividend Junior | 2023-08-11 | Annually | 18 | 0.50% | |
DHRUV.NS | Dividend Junior | 2023-09-05 | Insufficient data to determine frequency | 2 | 0.15% | |
SOBHA.NS | Dividend Junior | 2023-07-28 | Annually | 18 | 0.43% | |
MMP.NS | Dividend Junior | 2023-08-18 | Annually | 4 | 0.49% | |
HDFC.NS | Dividend Junior | 2023-05-16 | Annually | 23 | 0.85% | |
BHAGCHEM.NS | Dividend Junior | 2023-07-27 | Annually | 4 | 0.14% | |
RAIN.NS | Dividend Junior | 2023-05-19 | Annually | 18 | 0.39% | |
KIRLOSBROS.NS | Dividend Junior | 2023-07-25 | Annually | 17 | 0.99% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0818 | 1.500 | 8.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.128 | 1.500 | 9.69 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 26.92 | 1.000 | 1.142 | 1.142 | [3 - 30] |
operatingCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 7.90 | [0 - 30] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 0.929 | 1.857 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.547 | 1.000 | 4.22 | 4.22 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0995 | 1.000 | -0.00989 | -0.00989 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.790 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.59 | 1.000 | 6.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.128 | 2.50 | 9.80 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 1.857 | [0 - 30] |
dividendYielPercentageTTM | 0.628 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 7.90 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0254 | 1.500 | -3.16 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0341 | 1.000 | -1.648 | 0 | [0.1 - 0.5] |
Total Score | 3.58 |
TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.